HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 70, Issue 7, Pages 2084-2089
Publisher
Oxford University Press (OUP)
Online
2017-02-03
DOI
10.1093/jac/dkv049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain
- (2014) Rocío Sierra-Enguita et al. AIDS
- Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007–2013
- (2014) Joanne D Stekler et al. ANTIVIRAL THERAPY
- Antiretroviral Treatment of Adult HIV Infection
- (2014) Huldrych F. Günthard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
- (2014) Dineke Frentz et al. PLoS One
- Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic
- (2014) Andrea-Clemencia Pineda-Peña et al. PLoS One
- Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade
- (2013) Gonzalo Yebra et al. ARCHIVES OF VIROLOGY
- National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011
- (2013) D. Descamps et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses
- (2013) S. Lambert-Niclot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection
- (2013) Charline Bacchus et al. PLoS One
- Preexisting mutations in the rilpivirine Phase III trials ECHO and THRIVE: prevalence and impact on virologic response
- (2012) Johan Vingerhoets et al. ANTIVIRAL THERAPY
- Analysis of transmitted drug resistance in Spain in the years 2007–2010 documents a decline in mutations to the non-nucleoside drug class
- (2012) S. Monge et al. CLINICAL MICROBIOLOGY AND INFECTION
- Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010
- (2012) M. Colafigli et al. CLINICAL MICROBIOLOGY AND INFECTION
- Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study
- (2012) BMJ-British Medical Journal
- Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe
- (2009) Jurgen Vercauteren et al. JOURNAL OF INFECTIOUS DISEASES
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
- (2009) Diane E. Bennett et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started